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Abstract
Objective. Barlow disease is a still challenging pathology for the surgeon. Aim of the present study 
is to report anatomic abnormalities of mitral valve in patients undergoing mitral valve repair.
Methods. Between January 1st, 2007, and December 31st, 2010, 85 consecutive patients (54 men 
and 31 women, mean age 59 ±14 years - range: 28-85 years) with the features of a Barlow mitral 
valve disease underwent mitral repair Forty seven percent of patients were in New York Heart 
Association functional class III or IV. Preoperative transesophageal echocardiography was com-
pared with anatomical findings at the moment of surgery.
Results. Transthoracic echocardiography diagnosis of Barlow disease according to the crite-
ria described by Carpentier was confirmed at anatomical inspection. Annular calcifications 
were found in 28 patients while 7 patients presented single or multiple clefts. A flail posterior 
mitral leaflet was detected in 32 subjects, while a flail anterior leaflet in 8. Elongation of chordae 
tendineae was demonstrated in 45 patients and chordal rupture in 31. All patients showed at 
trans esophageal echocardiography the typical features of Barlow disease. Seventy-seven (90.6%) 
patients had severe mitral valve regurgitation, in the remaining 9.4% it was moderate to severe. 
Transesophageal echocardiography failed to identify clefts in 2/7 and chordal rupture in 4/31. 
Conclusions. bileaflet prolapse > 2 mm, billowing valve with excess tissue and thickened leaf-
lets ≥ 3 mm, and severe annular dilatation, are characteristics of Barlow disease, however the 
identification of the associated and complex abnormalities of mitral valve is necessary to obtain 
optimal valve repair. 
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Background
Barlow disease is a relatively common cause of mitral regurgitation, secondary 
to bileaflet multisegment prolapse (Carpentier’s type II dysfunction). The anatom-
ic features of the disease include myxoid degeneration of all components of mitral 
valve apparatus, with excessive leaflets tissue involving all the scallops, severe annu-
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lar dilatation and multi-jet mitral regurgitation (Anyanwu and Adams, 2007). Aeti-
ology of Barlow disease is at present unknown, however familial aggregation has 
been described. Recently Lardeaux et al (2011) in a French family have been able to 
identify three filamin A mutations, p.Gly288Arg and p.Val711Asp, and a 1,944-bp 
genomic deletion coding for exons 16 to 19. The recent finding of co-existence of Bar-
low’s disease and axillary artery aneurysms in two brothers raises the possibility the 
disease to be part of a connective tissue disorder (Kasahara et al., 2012). Myxoma-
tous degeneration of the extracellular matrix may depend on genetic and less often 
acquired conditions, with enahanced activity of matrix metallo proteases and cysteine 
endoproteases and local absence of tenomodulin (Guy and Hill, 2012) The disease is 
defined according to the criteria described by Carpentier (Carpentier et al.,1980; Car-
pentier, 1983) as a bileaflet prolapse > 2 mm, billowing valve with excess tissue and 
thickened leaflets ≥ 3 mm, and severe annular dilatation. Chordal elongation or rup-
ture, annular and papillary muscle calcification may be present.
The goals of reconstructive surgery are preservation or restoration of normal leaf-
let motion, creation of a large surface of coaptation, and stabilization of the entire 
annulus with a remodelling annuloplasty (Savage et al., 2003; Adams et al., 2010). 
Support is restored by resection of prolapsing segments, chordal transfer, applica-
tion of neochordae, or papillary muscle–repositioning. The sliding plasty technique 
may also be used to restore appropriate tension on mildly elongated chordae. Areas 
of leaflet and chordal calcification or fusion should be resected to restore mobility 
of the leaflet(s). Annular dilation is addressed by annular plication and annuloplas-
ty (Carpentier et al., 1995). Aim of present investigation was to evaluate, in a single 
high-volume centre, the anatomical abnormalities of mitral valve apparatus observed 
at surgery in patients undergoing mitral valve repair and to compare them with 
transesophageal echocardiographic (TEE) findings.
Materials and methods
Between January 1st, 2007, and December 31st. 2010, 85 consecutive patients (54 
men and 31 women; mean age 59 ±14 years) presented at the authors’ centre with 
features of Barlow Disease. All procedures were performed by a single surgeon. Bar-
low Disease was recognized by preoperative echocardiogram and confirmed at surgi-
cal inspection. Patients presenting features of fibroelastic deficiency and Marfan dis-
ease were excluded from the study.
Preoperative examinations
Transthoracic echocardiography (TTE) and TEE were performed in all patients 
before surgery and the echocardiograms were reviewed by a senior cardiologist. TEE 
was also performed during surgical intervention in all cases. 
Surgery
Full sternotomy was performed in most cases (94.1%), whereas in 5 patients (5.9%) 
a minimally invasive approach through a smaller incision at the fourth right intercos-
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tal space was possible. Mitral valve was accessed through a left atriotomy in the inter-
atrial groove and the repair was performed according to the principles described by 
Carpentier et al ( 1995). Accurate inspection with assessment of abnormalities of mitral 
valve anatomy allowed the choice of the strategy for mitral valve repair. 
Statistical Analysis
Data are presented as mean ± standard deviation for continuous variables, as number 
and percentage for categorical variables, and as median for non-parametric variables.
Results
The clinical and echocardiographic characteristics of patients entered in the study 
are reported in Table 1 and 2. The main preoperative comorbidities were atrial fibril-
lation (31.8%) and hypertension (31.8%), Forty seven percent were in advanced New 
York Heart Association (NYHA) functional class (III or IV). TTE and TEE revealed 
dilated left atrium and dilated left ventricle with increased end-systolic and end-dias-
tolic volumes. Mean left ventricular ejection fraction was 62%,. Seventy-seven (90.6%) 
patients had severe mitral valve regurgitation, in the others (9.4%) regurgitation was 
evaluated as moderate to severe. 
At valve examination during surgery all patients showed bileaflet prolapse > 2 
mm, billowing valve with excess tissue and thickened leaflets, and severe anular dila-
Table 1 – Patients characteristics (n=85).
Number of Patient 85
Age (years) [range] 59 ± 14 [28-85]
Gender M/F 54/31 
BSA (m2) [range] 1.84 ± 0.20 [1.35-2.38]










Chronic Renal Disease 2 (2.3)
Abbreviations. M/F: Male/Female; BSA: Body Surface Area; NYHA: New York Heart Association; COPD: Chronic 
Obstructive Pulmonary Disease.
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tation. In addition to these findings, which confirmed the diagnosis of Barlow dis-
ease, in 28 (33.0%) patients annular calcifications were found and 7 patients present-
ed single or multiple clefts. A flail posterior mitral leaflet was detected in 32 (37%) 
subjects, while a flail anterior leaflet in 8 (9%). Elongation of chordae tendineae was 
demonstrated in 45 (53.0%) and chordal rupture in 31 (36.5%); the finding of papil-
lary muscles elongation or calcification was rare (Figure 1). 
All patients showed at TTE and TEE the typical features of Barlow disease (Fig-
ure 2). Seventy-seven (90.6%) patients had severe mitral valve regurgitation, in the 
remaining 9.4% it was moderate to severe. TEE failed to identify clefts in 2/7 and 
chordal rupture in 4/31.
Mitral valve echocardiographic and inspective pathological characteristics are 
reported in Table 3.
The operative techniques adopted on the basis of anatomical evaluation are 
reported in Table 4. 
Discussion
In patients with bileaflet mitral valve prolapse, adequate preoperative evaluation 
of anatomic abnormalities through preoperative TEE and visual inspection at sur-
gery allows to choice the more appropriate surgical strategy of mitral valve repair to 
obtain an optimal functional correction (Anyanwu and Adams, 2010). 
Few studies have reported the anatomical abnormalities of mitral valve apparatus 
Table 2 – Bidimensional echocardiographic features.
Echocardiographic Parametres
EDD (mm) 58.02±6.14 [40-73]
ESD (mm) 34.81±6.88 [21-60]
ST (mm) 10.32±1.42 [7-14]
WT (mm) 10.04±1.27 [7-14]
EDV (ml) 152.40±43.91 [52-287]
ESV (ml) 55.84±19.54 [15-132]
EDVI (ml/m2) 82.30±19.36 [31-138]
ESVI (ml/m2) 30.26±9.36 [9-71]
LVEF (%) 62.32±7.11 [45-76]
LAD M-mode (mm) 47.95±6.47 [36-67]
LA Area (cm2) 28.50±7.46 [17-50]
PAP mean (mmHg) 37.08±15.88 [20-120]
Abbreviations. EDD: End-Diastolic Diameter; ESD: End-Systolic Diameter; ST: Septum Thickness; WT: Wall 
Thickness; EDV: End-Diastolic Volume; ESV: End-Systolic Volume; EDVI: End-Diastolic Volume Index; ESVI: End-
Systolic Volume Index; LVEF: Left Ventricular Ejection Fraction; LAD: Left Atrium Diameter; LA: Left Atrium; 
PAP: Pulmonary Artery Pressure.
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in Barlow disease and their relation with surgical strategy and clinical outcome. In 
particular the identification of further leaflets abnormalities, such as valve clefts, and 
of chordal integrity or elongation may suggest additional repair techniques to the 
surgeon, such as chordal transfer, application of neochordae, or use of sliding plas-
ty technique that may improve surgical results and long term maintenance of valve 
competence (David et al., 2005; Adams et al., 2006a; Schaff et al., 2007). 
In our study elongation of chordae tendineae and chordal rupture were found 
in more than 40% of patients. Leaflet clefts in 8% and anular calcification in 33%. 
Flail was more common for posterior leaflet. In the paper by Flameng et al. (2008) 
83 patients with Barlow disease were examinated. The incidence of leaflets clefts and 
chordal rupture were similar to that found in our patients. Elongation of chordae 
tendinae and mitral annulus calcification were less frequent than in our population. 
Mean age of patients was not significantly different ( 61 years in the study by Fla-
meng et al in comparison to our patients). 
The risk of late failure presents two phases: a peaking early risk phase in the 
first year followed by a slow-rising late phase with risk of undergoing reoperation 
Figure 1 – Anatomical findings in Barlow disease (atrial views): A) Floppy mitral valve with bileaflet prolapse, 
thickened leaflets and dilated annulus, B ) Severe thickening of posterior leaflet with severe prolapse of the 
free edge c) anterior papillary muscle calcifications, fusion of chordae tendinee leading to decreased ampli-
tude of P1-P2 junction. D) atrialization of left posterior leaflet, presene of “clefts “ and thrombosis ( arrows).
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(Dumont et al., 2007). This may be due to the surgical technique or to valve-relat-
ed factors, and is well recognized that the process of tissue degeneration, involving 
mainly the chordae, goes further after surgical correction, leading to recurrent regur-
gitation from chordal rupture or elongation; the implantation of artificial chordae is 
described to be associated to better outcomes, probably because they can prevent, at 
Table 3 – Mitral Valve Analysis (n=85).
Echocardiographic Findings
Mitral Valve Regurgitation n (%)
Moderate-Severe 8 (9.4)
Severe 77 (90.6)
Vena Contracta (cm) 0.74±0.16 [0.3-1.1]
EROA (cm2) 0.58±0.26 [0.25-1.6]
Anulus AP (mm) 43.05±3.92 [33-55]
Surgical lesions: number (%) Visual inspection               TEE
Excess Tissue* 85 (100)                            85 (100)
Bileaflet Prolapse* 85 (100)                            85 (100)
Leaflet Thickening* 85 (100)                            85 (100)
Anular Dilatation* 85 (100)                            85 (100)
Anular Calcification 28 (33)                              27 (31)
Chordae Elongation 45 (53)                              45 (53) 
Chordae Rupture 31 (36)                              27 (31)
Multiple Clefts 7 (8)                                   5 (6)
Flail AML 8 (9)                                   8 (9)
Flail PML  32 (37)                             32 (37) 
Abbreviations. EROA: Effective Regurgitant Orifice Area; AP: Anterior-Posterior; PM: Papillary Muscle; AML: 
Anterior Mitral Leaflet; PML: Posterior Mitral Leaflet; TEE: Trans Esophageal Echocardiography.
* Fundamental criteria to define Barlow’s Disease at surgical inspection.
Table 4 – Operative techniques.
Type of Surgical Intervention: number (%)
PMLQR + Prosthetic ring 20 (23.5)
PMLQR + Prosthetic ring + Neochordae 13 (15.3)
PMLQR + Sliding PML + Prosthetic ring 20 (23.5)
PMLQR + Sliding PML + Prosthetic ring + Neochordae 23 (27.1)
Prosthetic ring + Neochordae 9 (10.6)
Abbreviations. PMLQR: Posterior Mitral Leaflet Quadrangular Resection; PML: Posterior Mitral Leaflet.
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Figure 2 – Barlow diasease at 2-D echocardiography A) short axis showing thickened and redundant mitral 
leaflets, B ) long axis demonstrates severe bileaflet prolapse with thickened chordae tendinee.
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some extent, the disease to progress; we used artificial chordae in more than a half of 
cases, and this proportion is increasing in our more recent experience. 
Repair of the mitral valve is currently the best surgical treatment for complex 
degenerative mitral valve disease and should be pursued even in the most advanced 
forms of Barlow disease. Careful selection of patients, accurate description of ana-
tomical abnormalities leading to optimization of surgical techniques including use 
of large size annuloplasty rings (Adams et al., 2006b) and of artificial chordae, along 
with surgical expertise in mitral valve repair, are the main determinants to reduce the 
risk of recurrent mitral regurgitation and to ensure a better outcome.
References
Adams D.H., Anyanwu A.C,. Rahmanian P.B., Abascal V., Salzberg S.P., Filsoufi F. 
(2006a) Large annuloplasty rings facilitate mitral valve repair in Barlow’s disease. 
Ann. Thorac. Surg. 82: 2096-2101.
Adams D.H.,. Anyanwu A.C,. Rahmanian P.B, Filsoufi F. (2006b) Current concepts in 
mitral valve repair for degenerative disease. Heart Failure Rev. 11: 241-257.
Adams D.H., Rosenhek R., Falk V. (2010) Degenerative mitral valve regurgitation: 
best practice revolution. Eur. Heart J. 31: 1958-1967.
Anyanwu A.C., Adams D.H. (2007) Etiologic classification of degenerative mitral 
valve disease: Barlow’s disease and fibroelastic deficiency. Semin. Thorac. Cardio-
vasc. Surg. 19: 90-96.
Anyanwu A.C., Adams D.H, (2010). Bileaflet repair for Barlow syndrome. Semin. 
Thorac. Cardiovasc. Surg. 22: 179-183.
Carpentier A., Chauvaud S., Fabiani J.N., Deloche A., Relland J., Lessana A., 
D’Allaines C., Blondeau P., Piwnica A., Dubost C. (1980) Reconstructive surgery 
of mitral valve incompetence: ten-year appraisal. J. Thorac. Cardiovasc. Surg. 79: 
338-348.
Carpentier A. (1983) Cardiac valve surgery - the “French correction. J. Thorac. Cardio-
vasc. Surg. 86: 323-337.
Carpentier A.F., Lessana A., Relland J.Y., Belli E., Mihaileanu S., Berrebi A.J., Palsky 
E., Loulmet D.F. (1995). The “Physio-Ring”: an advanced concept in mitral valve 
annuloplasty. Ann. Thorac. Surg. 60: 1177-1185.
David T.E., Ivanov J., Armstrong S., Rakowski H. (2003). Late outcomes of mitral 
valve repair for floppy valves: implications for asymptomatic patients. J. Thorac. 
Cardiovasc. Surg. 125: 1143-1152.
Dumont E., Gillinov A.M., Blackstone E.H., Sabik J.F. 3rd, Svensson L.G., Mihaljevic 
T., Houghtaling P.L., Lytle B.W. (2007) Reoperation after mitral valve repair for 
degenerative disease. Ann. Thorac. Surg. 84: 444-450.
Flameng W., Meuris B., Herijgers P., Herregods M.-C. (2008) Durability of mitral 
valve repair in Barlow disease versus fibroelastic deficiency. J. Thorac. Cardiovasc. 
Surg. 135: 274-282.
Guy T.S., Hill A.C. (2012) Mitral valve prolapse. Annu. Rev. Med. 63: 277-292.
Kasahara H., Kudo M., Yozu R., Hosoda S., Shiikawa A. (2012) Combination of famil-
ial Barlow’s disease with bilateral axillary artery aneurysms in two brothers. Gen. 
Thorac. Cardiovasc. Surg. 60: 115-117. 
28 Carlo Rostagno et alii
Lardeux A., Kyndt F., Lecointe S., Marec H.L., Merot J., Schott J.J., Le Tourneau T., 
Probst V. (2011) Filamin-a-related myxomatous mitral valve dystrophy: genetic, 
echocardiographic and functional aspects. J. Cardiovasc. Transl. Res. 4: 748-756.
Savage E.B., Ferguson T.B. Jr, Di Sesa V.J.( 2003) Use of mitral valve repair: analysis 
of contemporary United States experience reported to the Society of Thoracic Sur-
geons National Cardiac Database. Ann. Thorac. Surg. 75: 820-825.
Schaff H.V., Suri R.K., Phil D., Enriquez-Sarano M. (2007) Indications for surgery in 
degenerative mitral valve disease. Semin. Thorac. Cardiovasc. Surg. 19: 97-102.
